Xenon Pharmaceuticals XENE Other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025)
Other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025) at other companies
Other financials
Where this comes from
Reported directly by Xenon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherReceivablesNetCurrent.
The official record: Xenon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xenon Pharmaceuticals's other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xenon Pharmaceuticals's other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025)?
- Xenon Pharmaceuticals (XENE) reported other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025) of $1.17M in Q1 2026.